Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC16H20F2N8O2 |
InChIKeyVZVYLEDIUUZTCW-UHFFFAOYSA-N |
CAS Registry1927857-55-3 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | CH | 03 Sep 2019 |